Penetrating keratoplasty-induced glaucoma
Secondary glaucoma after penetrating keratoplasty is a common and serious complication. On the one hand, increased intraocular pressure damages the function of corneal graft endothelial cells, which is one of the main reasons for corneal transplant failure after graft rejection. On the other hand, it also causes irreversible damage to the optic nerve, ultimately leading to loss of visual function. With the development of ophthalmic microsurgery technology and immunotherapy research, the indications for keratoplasty are constantly expanding. Although the incidence of early postoperative glaucoma related to wound leakage and graft adhesion has decreased, the anterior segment lesions are becoming more and more complicated, and secondary glaucoma is still a common and serious complication after surgery.
-
Site of disease:
Eye -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Eye swelling headache scleral perforation visual impairment eye pain -
Concurrent disease:
Related Drugs
Methazolamide Tablets
Indication: It is used as an adjuvant treatment for patients with primary open-angle glaucoma, angle-closure glaucoma and some secondary glaucoma whose intraocular pressure is not well controlled by topical anti-glaucoma drugs. Because this product has less effect on acid-base balance while lowering intraocular pressure, it is better than acetazolamide for patients with severe obstructive pulmonary disease. Methazolamide has less effect on urinary citrate secretion than acetazolamide, so it is recommended for patients who need oral carbonic anhydrase inhibitor treatment but are prone to kidney stone formation.
Manufacturer:
Hangzhou Qianyuan Baoling Pharmaceutical Co., Ltd.
Related Ingredients